FREEHOLD, N.J., Sept. 1, 2005 (PRIMEZONE) -- New Life Scientific, Inc. ("New Life") (OTCBB:NWLF) www.newlifesci.com, an emerging bio-tech company, today announced that it will be a presenting company at the 2005 ValueRich Small Cap Financial Exposition -- being held at the Jacob K. Javits Convention Center on September 14 and 15.
New Life's President, Wes J. Bochenek, M.D, Ph.D, F.A.C.P., will deliver a presentation on Thursday, September 15, 2005 at 10:00 a.m., in which he will discuss New Life Scientifics progress and development.
Please visit New Life's exhibit booth Number 166 to meet the Company's management and learn more about their business plan. Registration information is available by going to www.valuerichonline.com.
About New Life Scientific, Inc.
New Life Scientific, Inc., through its wholly owned subsidiary, Novo Life Scientific (Ukraine) intends to use The Institute of Molecular Biology and Genetics technology in biomedicine to develop and market stem cell lines and to establish a stem cell bank. The company is researching and developing the business model for creating stem cell banks and stem cell treatment facilities in eastern Europe. In addition, New Life Scientific, through its other subsidiary, Pharma Trials, provides services in the areas of clinical trials, market research, and the regulatory approval of products for pharmaceutical companies and contract research organizations. It has a strategic alliance with INVAPHARM LLC. New Life Scientific is based in Freehold, New Jersey.
For further information on New Life Scientific, please visit www.newlifesci.com
You may register to receive New Life Scientific's future press releases and to be added to the Company's distribution list by contacting Emerging Markets Consulting, LLC: 1(321) 206-6682.
The above news release contains forward-looking statements. These statements are based on assumptions that management believes are reasonable, based on currently available information, and include statements regarding the intent, belief or current expectations of the Company and its management. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performances, and are subject to a wide range of business risks, external factors and uncertainties. Actual results may differ materially from those indicated by such forward-looking statements. The Company assumes no obligation to update the information contained in this press release, whether as a result of new information, future events, or otherwise.